BioCurex, Inc.(fka BOCX)

[opportunityknocking]

Interesting avenue Recaf can also be used for: (Excerpt from previous post)

"In the project announced Tuesday, the FDA, National Cancer Institute and Medicare will collaborate to find better biomarkers for cancer, or better ways to measure and use them.
_____predict very early whether a patient is responding to treatment."
Dr Moro mentioned genetic testing to find out if an individual is predisposed, but it may also be used to see how an individual is responding to treatment.
I have been giving some thought to how best leverage the future press releases after the ISOBM, and I feel that the insurance companies will push hard to have their subscribers tested with Recaf. When the time is right let them know the benefits and cost savings of early detection by encouraging everyone to be tested.

Unrelated to my previous statement, does anyone know if any of the positions have been filled at the lab?